PDF
Word
This version of the form is not currently in use and is provided for reference only. Download this version of
Form HLTH5465
for the current year.
Form HLTH5465 Special Authority Request - Donepezil, Galantamine and Rivastigmine - British Columbia, Canada
Form HLTH5465 Special Authority Request - Donepezil, Galantamine and Rivastigmine - British Columbia, Canada is used for requesting special authority for the prescription drugs Donepezil, Galantamine, and Rivastigmine in the province of British Columbia. These medications are commonly used for treating Alzheimer's disease and related dementia.
The Form HLTH5465 Special Authority Request for Donepezil, Galantamine, and Rivastigmine in British Columbia, Canada is typically filed by healthcare professionals or physicians.
FAQ
Q: What is a Special Authority Request?
A: A Special Authority Request is a process in British Columbia, Canada, where certain medications require additional approval from the provincial health authority for coverage.
Q: What are Donepezil, Galantamine, and Rivastigmine?
A: Donepezil, Galantamine, and Rivastigmine are medications commonly used to treat Alzheimer's disease and related dementia.
Q: Who can request a Special Authority for these medications?
A: Patients, healthcare providers, or pharmacists can request a Special Authority for these medications.
Q: Why is a Special Authority Request needed for these medications?
A: A Special Authority Request is needed for these medications to determine if the patient meets the specific criteria set by the provincial health authority for coverage.
Q: How can I submit a Special Authority Request?
A: The process for submitting a Special Authority Request may vary. It is best to consult with your healthcare provider or pharmacist for specific instructions on how to submit the request in British Columbia, Canada.
